Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

City of Hope Medical Center

ClinicalTrials.gov Identifier:

NCT00645710

First received: March 27, 2008

Last updated: May 4, 2016

Last verified: May 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2017 (Final data collection date for primary outcome measure)